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In the past few years histopathologists in Great Britain have frequently been accused of diagnostic or professional incompetence, and their employers sought the names of assessors, reputable pathologists, to review a list of diagnostic mistakes. The results of the reviews have usually not been made known to the Royal College of Pathologists; the assessors, having negotiated their contracts directly with the employing NHS Trusts, produced the reports for the trust while the investigated pathologist was suspended or on the sick list. Reasons for an investigation are often hostility within the department or personality clashes, but frequently they remain obscure. Often the case is initiated by an article in a local newspaper, the pathologist being accused of a major mistake, the consequences of which may or may not be spelt out. Histopathologists are particularly vulnerable if they are involved in cancer screening programmes. Zero error is expected by the public and administrators, and the fear of litigation following a false negative diagnosis is beginning to threaten various screening programmes.
In June 1996 the College of American Pathologists hosted an international conference on liability and quality issues in cervical vaginal cytology where the standard of practice and possible solutions were discussed. 2 The Board of Directors of the California Society of Pathology issued guidelines for review of cervical smears in the context of potential litigation. Among many important points, the guidelines clearly state that zero error is an unreasonable expectation that cannot be achieved even with the use of automated re-screening devices, and that even skilled screening cytologists have an irreducible false negative rate of at least 5%. The California pathologists have accepted that all laboratories make mistakes and a false negative result is not necessarily evidence of substandard practice. Errors should not be judged in isolation but in the context of the overall performance of that laboratory. In their guidelines, the California Society of Pathology also warned against biased reviews performed with hindsight knowledge, and regarded as unethical reviewing by experts who did not practise routine diagnostic cytopathology. The society advised that the degree of diYculty should be established in a fashion simulating normal practice of "reasonable" cytologists without knowledge of the clinical outcome or litigation.
It seems logical to extend this method of reviewing errors to histopathological diagnosis where the variation of opinion and subjectivity of assessment by pathologists may frequently lead to variation in diagnoses that may be seen as errors. The results of studies concerned with error rates in histopathology vary widely (no serious errors, 3 0.26%, 4 up to 1.2% of histopathological reports 5 ) but these were performed in academic or teaching institutions.
During the past decade various presentations to the Pathological Society of Great Britain and Ireland demonstrated true interobserver variation, and this should be considered in calculating the likelihood of diagnostic errors in histopathology. In establishing what is an acceptable or realistic error-what variation of opinion is unavoidable-we could use the experience of the Scottish Panel for the Consistency of Histopathological Reporting who, over the years, examined observer variability in the reporting of biopsies results of the cervix, bladder, rectum, bronchus and, recently, prostate. 6 The panel established that pathologists are reliable in recognising the entity but inconsistent in quantifying the degree (grade of tumours, depth of invasion). Similarly, a review of 100 randomly selected bronchial biopsies by 11 histopathologists 7 demonstrated generally good ability to distinguish between small cell and non-small cell carcinoma, but great variation in subclassifying the non-small cell tumours. Dermott and colleagues 8 found considerable disagreement between six observers assessing radial and vertical growth of malignant melanoma in a large proportion of 94 investigated cases, immediately after the pathologists had read the article describing the benefits and pitfalls of that method. The Leicester local external quality assessment system (EQAS) results of measuring Breslow depths of malignant melanoma showed up to 84% agreement between pairs of observers, but agreement with the original report was as low as 74%. Colloby and colleagues 9 showed similar interobserver variation in measuring Breslow depth of thin cutaneous malignant melanoma.
Two experienced pathologists independently reviewing six classifications of ductal carcinoma in situ disagreed between grade I and II in 62.2%, between grade II and III in 39.9%, in the assessment of the architecture in 34.4%, and necrosis in 17.7% of cases. 10 Another study assessing the interobserver and intraobserver variability in identifying the area of greatest mitotic activity in breast carcinoma showed wide variations in both area selection and the mitotic counts. 11 It has been shown previously that there is poor agreement between establishing the grade and subtype of invasive breast carcinoma and presence of atypical hyperplasia. 12 Major diVerences of opinion and great interobserver variation occur in instances where grading has to be used, cervical intraepithelial neoplasia (CIN) being the most common field of disagreement. This has been a subject of several studies over the past 15 years, and a recent article by McCluggage et al suggests that there has been no improvement. 13 It is not just poor agreement in the diVerentiation of low grades of CIN from koilocytosis but also distinction of CIN II and III from normal squamous epithelium and immature squamous metaplasia. The interobserver agreement among six independent histopathologists of 125 consecutive colposcopic cervical biopsy samples using CIN and Bethesda grading systems was poor, with values ranging from 0.05 to 0.34 and 0.2 to 0.54 between individual pairs. In addition, the contribution of gynaecologists in supplying poor, unrepresentative, or misleading samples may not be negligible. 14 When BanV criteria for histological diagnosis of rejection were used in renal allograph biopsies, acute rejection was overestimated, and in 14 of the 38 biopsy samples labelled borderline, the clinical diagnosis was that of acute rejection. The subjective nature of diagnosing abnormality of duodenal mucosa was demonstrated in a blind, retrospective review of paediatric samples of duodenal/jejunal mucosa: the diagnosis was changed in nine of 80 cases. 15 The system of retrospective assessment of another pathologist's work by two willing assessors working for a fee, producing a report with recommendations for the employer but not for the College, may be seen as punitive and unfair. It does not reflect the initial diagnostic situation, the assessors may not have worked independently, and they know there has been a complaint. Even if the alleged incompetence is not confirmed, clearing one's name is not easy, and "not guilty" is not the same as innocent. A detailed account of one case with subsequent reaction, was published in ACP News, 16 and there are other cases with similar destruction of professional reputation and private life.
Having become members of the College by examination, we have proved that we have reached the required standard of diagnostic competence. Taking part in external quality assessment and continuing medical education activities helps us keep up to date with new developments in our specialties. Many members feel that it should be the College that decides whether they are still competent and that the College should determine when an error is significant. The Royal College of Pathologists is balancing its function between upholding high standards, while accepting that errors are unavoidable, and looking after its members, none of whom is infallible. At present, the defence of an erring pathologist is diYcult for the Medical Defence Union and Medical Protection Society as the acceptable error rate of a "reasonable" pathologist has not been defined. 17 It has been suggested in the USA that false negative rates of 5-10% may be an admirable goal in cytopathology, and rates below 15-20% are a possible standard. 18 We have witnessed the destructive eVect of media publicity concerning various reviews of cervical screening and mammography on recruitment to the specialties, and we can hardly fathom the costs of these reviews to the NHS. Are we not able to explain to the public that all diagnostic and screening procedures aim for the correct diagnosis but carry a certain rate of error, which does not mean incompetence, and that zero error cannot be expected?
Suspension of an experienced consultant pathologist, a review of that pathologist's work, and the employment of a locum pathologist is probably more expensive than financial compensation for the damage caused to a patient by the pathologist's diagnostic error, if such a mistake truly occurred. The role of clinicians in the investigation of a patient should not be overlooked. They supply the pathologist with clinical information-which we expect to be correct and relevant-and, with their knowledge of the patient, they should be able to detect or suspect that the proVered pathological diagnosis may be wrong. When does the
